title: Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB.
abstract: Fc gamma RIIB are single-chain low-affinity receptors for IgG that bear an immunoreceptor tyrosine-based inhibition motif in their intracytoplasmic domain and that negatively regulate immunoreceptor tyrosine-based activation motif-dependent cell activation. They are widely expressed by cells of hematopoietic origin. We investigated here whether Fc gamma RIIB could also negatively regulate protein tyrosine kinase receptor (RTK)-dependent cell proliferation. As an experimental model, we used growth factor-dependent mast cells that constitutively express Fc gamma RIIB and c-kit, an RTK prototype. We found that anti-c-kit Abs mimicked the effect of stem cell factor and induced thymidine incorporation in Fc gamma RIIB-/-, but not in wild-type (wt) mast cells unless Fc gamma RIIB were blocked or anti-c-kit F(ab')2 were used. When coaggregated with c-kit by intact Abs in wt mast cells, Fc gamma RIIB inhibited thymidine incorporation, as well as cell proliferation, and inhibition was correlated with an arrest of cells in G1 during the cell cycle. The coaggregation of c-kit with Fc gamma RIIB did not affect ligand-induced c-kit phosphorylation and induced the tyrosyl-phosphorylation of Fc gamma RIIB, which selectively recruited the Src homology 2 domain-bearing inositol 5-phosphatase SHIP. Our results indicate that IgG Abs to growth factors or growth factor receptors may control RTK-dependent proliferation of a variety of cells that express Fc gamma RIIB.
authors: Laboratoire d'Immunologie Cellulaire et Clinique, Institut National de la Santé et de la Recherche Médicale Unité 255, Institut Curie, Paris, France.
authors: O
authors: O
authors: Malbec
authors: W H
authors: WH
authors: Fridman
authors: M
authors: M
authors: Daëron
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000378:metabolism / Q000502:physiology*; D001854:Bone Marrow Cells / Q000378:metabolism; D002455:Cell Division / Q000276:immunology; D015536:Down-Regulation / Q000276:immunology*; D006131:Growth Inhibitors / Q000276:immunology; D007106:Immune Sera / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000276:immunology*; D008407:Mast Cells / Q000166:cytology / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D000072183:Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D010766:Phosphorylation; D019009:Proto-Oncogene Proteins c-kit / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D011940:Receptor Aggregation / Q000276:immunology; D017452:Receptors, IgG / Q000378:metabolism / Q000502:physiology*; D013936:Thymidine / Q000378:metabolism; D018909:src Homology Domains / Q000276:immunology
chemical_list: D015703:Antigens, CD; C080571:Fc gamma receptor IIB; D006131:Growth Inhibitors; D007106:Immune Sera; D017452:Receptors, IgG; D019009:Proto-Oncogene Proteins c-kit; D010744:Phosphoric Monoester Hydrolases; C098706:INPPL1 protein, human; D000072183:Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; D013936:Thymidine